Cargando…

An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells

INTRODUCTION: About 70% of breast cancers express oestrogen receptor α (ESR1/ERα) and are oestrogen-dependent for growth. In contrast with the highly proliferative nature of ERα-positive tumour cells, ERα-positive cells in normal breast tissue rarely proliferate. Because ERα expression is rapidly lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Duss, Stephan, André, Sylvie, Nicoulaz, Anne-Laure, Fiche, Maryse, Bonnefoi, Hervé, Brisken, Cathrin, Iggo, Richard D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929103/
https://www.ncbi.nlm.nih.gov/pubmed/17573968
http://dx.doi.org/10.1186/bcr1734
_version_ 1782134259926958080
author Duss, Stephan
André, Sylvie
Nicoulaz, Anne-Laure
Fiche, Maryse
Bonnefoi, Hervé
Brisken, Cathrin
Iggo, Richard D
author_facet Duss, Stephan
André, Sylvie
Nicoulaz, Anne-Laure
Fiche, Maryse
Bonnefoi, Hervé
Brisken, Cathrin
Iggo, Richard D
author_sort Duss, Stephan
collection PubMed
description INTRODUCTION: About 70% of breast cancers express oestrogen receptor α (ESR1/ERα) and are oestrogen-dependent for growth. In contrast with the highly proliferative nature of ERα-positive tumour cells, ERα-positive cells in normal breast tissue rarely proliferate. Because ERα expression is rapidly lost when normal human mammary epithelial cells (HMECs) are grown in vitro, breast cancer models derived from HMECs are ERα-negative. Currently only tumour cell lines are available to model ERα-positive disease. To create an ERα-positive breast cancer model, we have forced normal HMECs derived from reduction mammoplasty tissue to express ERα in combination with other relevant breast cancer genes. METHODS: Candidate genes were selected based on breast cancer microarray data and cloned into lentiviral vectors. Primary HMECs prepared from reduction mammoplasty tissue were infected with lentiviral particles. Infected HMECs were characterised by Western blotting, immunofluorescence microscopy, microarray analysis, growth curves, karyotyping and SNP chip analysis. The tumorigenicity of the modified HMECs was tested after orthotopic injection into the inguinal mammary glands of NOD/SCID mice. Cells were marked with a fluorescent protein to allow visualisation in the fat pad. The growth of the graft was analysed by fluorescence microscopy of the mammary glands and pathological analysis of stained tissue sections. Oestrogen dependence of tumour growth was assessed by treatment with the oestrogen antagonist fulvestrant. RESULTS: Microarray analysis of ERα-positive tumours reveals that they commonly overexpress the Polycomb-group gene BMI1. Lentiviral transduction with ERα, BMI1, TERT and MYC allows primary HMECs to be expanded in vitro in an oestrogen-dependent manner. Orthotopic xenografting of these cells into the mammary glands of NOD/SCID mice results in the formation of ERα-positive tumours that metastasise to multiple organs. The cells remain wild type for TP53, diploid and genetically stable. In vivo tumour growth and in vitro proliferation of cells explanted from tumours are dependent on oestrogen. CONCLUSION: We have created a genetically defined model of ERα-positive human breast cancer based on normal HMECs that has the potential to model human oestrogen-dependent breast cancer in a mouse and enables the study of mechanisms involved in tumorigenesis and metastasis.
format Text
id pubmed-1929103
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19291032007-07-21 An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells Duss, Stephan André, Sylvie Nicoulaz, Anne-Laure Fiche, Maryse Bonnefoi, Hervé Brisken, Cathrin Iggo, Richard D Breast Cancer Res Research Article INTRODUCTION: About 70% of breast cancers express oestrogen receptor α (ESR1/ERα) and are oestrogen-dependent for growth. In contrast with the highly proliferative nature of ERα-positive tumour cells, ERα-positive cells in normal breast tissue rarely proliferate. Because ERα expression is rapidly lost when normal human mammary epithelial cells (HMECs) are grown in vitro, breast cancer models derived from HMECs are ERα-negative. Currently only tumour cell lines are available to model ERα-positive disease. To create an ERα-positive breast cancer model, we have forced normal HMECs derived from reduction mammoplasty tissue to express ERα in combination with other relevant breast cancer genes. METHODS: Candidate genes were selected based on breast cancer microarray data and cloned into lentiviral vectors. Primary HMECs prepared from reduction mammoplasty tissue were infected with lentiviral particles. Infected HMECs were characterised by Western blotting, immunofluorescence microscopy, microarray analysis, growth curves, karyotyping and SNP chip analysis. The tumorigenicity of the modified HMECs was tested after orthotopic injection into the inguinal mammary glands of NOD/SCID mice. Cells were marked with a fluorescent protein to allow visualisation in the fat pad. The growth of the graft was analysed by fluorescence microscopy of the mammary glands and pathological analysis of stained tissue sections. Oestrogen dependence of tumour growth was assessed by treatment with the oestrogen antagonist fulvestrant. RESULTS: Microarray analysis of ERα-positive tumours reveals that they commonly overexpress the Polycomb-group gene BMI1. Lentiviral transduction with ERα, BMI1, TERT and MYC allows primary HMECs to be expanded in vitro in an oestrogen-dependent manner. Orthotopic xenografting of these cells into the mammary glands of NOD/SCID mice results in the formation of ERα-positive tumours that metastasise to multiple organs. The cells remain wild type for TP53, diploid and genetically stable. In vivo tumour growth and in vitro proliferation of cells explanted from tumours are dependent on oestrogen. CONCLUSION: We have created a genetically defined model of ERα-positive human breast cancer based on normal HMECs that has the potential to model human oestrogen-dependent breast cancer in a mouse and enables the study of mechanisms involved in tumorigenesis and metastasis. BioMed Central 2007 2007-06-15 /pmc/articles/PMC1929103/ /pubmed/17573968 http://dx.doi.org/10.1186/bcr1734 Text en Copyright © 2007 Duss et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Duss, Stephan
André, Sylvie
Nicoulaz, Anne-Laure
Fiche, Maryse
Bonnefoi, Hervé
Brisken, Cathrin
Iggo, Richard D
An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells
title An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells
title_full An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells
title_fullStr An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells
title_full_unstemmed An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells
title_short An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells
title_sort oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929103/
https://www.ncbi.nlm.nih.gov/pubmed/17573968
http://dx.doi.org/10.1186/bcr1734
work_keys_str_mv AT dussstephan anoestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT andresylvie anoestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT nicoulazannelaure anoestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT fichemaryse anoestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT bonnefoiherve anoestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT briskencathrin anoestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT iggorichardd anoestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT dussstephan oestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT andresylvie oestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT nicoulazannelaure oestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT fichemaryse oestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT bonnefoiherve oestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT briskencathrin oestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells
AT iggorichardd oestrogendependentmodelofbreastcancercreatedbytransformationofnormalhumanmammaryepithelialcells